Exhibit 99

            CERTIFICATION OF CHIEF EXECUTIVE OFFICER
               PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with  the  IGENE Biotechnology,  Inc.  (the
"Company")  Quarterly Report on Form 10-QSB for the period  ended
September  30,  2002, as filed with the Securities  and  Exchange
Commission  on  the date hereof (the "Report"),  I,  Stein  Ulve,
Chief  Executive Officer of the Company, certify pursuant  to  18
U.S.C.  Section 1350, as adopted pursuant to Section 906  of  the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

          (1). The Report fully complies with the requirements of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934, as amended; and

          (2).  The  information contained in the  Report  fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date: March 31, 2003            By:  /s/ STEIN ULVE
                                    _____________________________
                                         STEIN ULVE
                                         Chief Executive Officer